Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data()

BACKGROUND: There is uncertainty about the cost effectiveness of early intensive treatment versus routine care in individuals with type 2 diabetes detected by screening. OBJECTIVES: To derive a trial-informed estimate of the incremental costs of intensive treatment as delivered in the Anglo-Danish-D...

Descripción completa

Detalles Bibliográficos
Autores principales: Laxy, Michael, Wilson, Edward C.F., Boothby, Clare E., Griffin, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086325/
https://www.ncbi.nlm.nih.gov/pubmed/29241888
http://dx.doi.org/10.1016/j.jval.2017.05.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086325/
https://www.ncbi.nlm.nih.gov/pubmed/29241888
http://dx.doi.org/10.1016/j.jval.2017.05.018

Ejemplares similares